Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6‐Mediated Drug‐Drug Interactions on Tramadol and O‐Desmethyltramadol Exposures via Allosteric and Competitive Inhibition

Tramadol is an opioid medication used to treat moderately severe pain. Cytochrome P450 (CYP) 2D6 inhibition could be important for tramadol, as it decreases the formation of its pharmacologically active metabolite, O‐desmethyltramadol, potentially resulting in increased opioid use and misuse. The ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Tao, Cristofoletti, Rodrigo, Cicali, Brian, Michaud, Veronique, Dow, Pamela, Turgeon, Jacques, Schmidt, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Physiologically Based Pharmacokinetic Modeling
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293201/
https://www.ncbi.nlm.nih.gov/pubmed/34383318
http://dx.doi.org/10.1002/jcph.1951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293201/
https://www.ncbi.nlm.nih.gov/pubmed/34383318
http://dx.doi.org/10.1002/jcph.1951

Ejemplares similares